ArticleTranslational oncology2026

Salvage therapy for radiorecurrent prostate cancer: beyond equipoise - a call for biomarker-driven stratification.

Qing-Hua Ke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.